Clinical Development of an Opioid Minimizing Combination Therapeutic
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Amalgent Therapeutics
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Malcolm Meyn
Fiscal Year
2023
Region
Eastern
Project Description:
Amalgent Therapeutics (Greenville, NC) is seeking 505(b)(2) approval for a fixed-dose oral tablet combination of two FDA approved drugs, morphine and pramipexole, that enables reduction of morphine to a less addictive dose. The SRL funds will be used to perform animal studies and prepare for a pre-IND meeting.